Editorial and Content Policy
Pillrecognizer.com mission is to be the Internet’s most trusted resource for drug and related health information. We are achieving this by presenting independent, objective, comprehensive and up-to-date information in a clear and concise format for both consumers and healthcare professionals.
The Pillrecognizer.com site-designers and engineers aim to provide visitors with an intuitive, user friendly website which is easy to navigate and provides rapid access to the extensive range of drug and related databases we have available. If you have problems with navigation or would like to suggest changes, please email us here. We review all comments about site-design and navigability at weekly design meetings.
The information available on the Pillrecognizer.com website is displayed under a number of licensing agreements with various publishers. For our drug-database information, we rely on the solid reputation of our suppliers: Cerner Multum, Micromedex and American Society of Health-System Pharmacists.
Referencing articles on Pillrecognizer.com
1) https://www.fda.gov/drugs/information-consumers-and-patients-drugs/find-information-about-drug
2) WHO Drug Information
https://www.who.int/our-work/access-to-medicines-and-health-products/who-drug-information
3) Drug Facts and Comparisons 2017 by Facts and Comparisons Staff
Call Number: QV 772 D79 2017 REF
ISBN: 9781574393767
Publication Date: 2016-10-29
https://libraryservices.acphs.edu/c.php?g=531947&p=3639451
Editorial Review Process
The editorial staff at Pillrecognizer.com constantly verifies that the material is correct and current by going over all submissions made by our many reliable medical publishing partners. Every article undergoes a minimum of one peer review by members of the Pillrecognizer.com team. Each document has a review and update status at the top or bottom.
Editorial Team
Physicians and registered pharmacists make up the editorial staff of Pillrecognizer.com. The editors of Pillrecognizer.com are always working to make the website better and easier to use.
Ajay Awase, PharmD
Senior Editorial Pharmacist
With over five years of experience developing drug information databases and publishing evidence-based medical articles, Ajay is a Drug Information Specialist with residency training. Immunology, pharmacology of drug interactions, over-the-counter and herbal nutritional supplements, and psychotropic drugs are among Leigh’s areas of expertise.
Content Policy
The content found on pillrecognizer.com is presented in accordance with the license agreements with the different publishers mentioned below.
Pillrecognizer.com Medicine and Health Information
Micromedex
Cerner Multum
American Society of Health-System Pharmacists
FDA Approved Product Labels
National Library of Medicine
Harvard Health Publications
Animalytix Veterinary Product Database
Medicine.com
New Drugs – FDA
News & Articles
FDA Newsletter
Pillrecognizer.com Drug Search Results
Four primary sources fuel the Pillrecognizer.com drug database: Micromedex, the American Society of Health-System Pharmacists, Cerner Multum (“Multum”), and FDA-approved product labels. The search results page for a given drug name may present the drug information in one of three formats:
Consumer Information, in English and Spanish
Advanced Consumer Information
Professional Information
Micromedex
Micromedex provides Comprehensive Drug Information for the Consumer on Pillrecognizer.com. The editorial crew of Detailed Drug Information for the Consumer, which consists of doctors, pharmacists, nurses, toxicologists, and other highly qualified drug professionals, has meticulously gathered and examined advanced consumer information regarding medications.
Cerner Multum
Consumer information regarding prescription medications and drugs is provided by Cerner Multum. Using a variety of sources, full-time employees with no connections to pharmaceutical corporations create the content for Multum. The Product Information/Package Insert, original literature, and data from standards organizations like the American Academy of Pediatrics, the World Health Organization, and the Centers for Disease Control and Prevention (CDC) are examples of initial references. After examining the updated data, doctors and pharmacists make any required modifications; one or more active clinical specialists evaluate each pamphlet. The Multum Expert Review Panel and mainstream, authorized medical textbooks are two examples of secondary references used to verify content.
American Society of Health-System Pharmacists
Today’s health professionals have access to the most comprehensive, authoritative, and unbiased source of drug information: AHFS DI, published by the American Society of Health-System Pharmacists (ASHP). AHFS DI content is thoroughly researched by a completely independent workforce of expert editorial and analytical staff, as well as drug information pharmacists. In order to guarantee that monographs have an evidence-based basis for safe and effective pharmacological therapy, authors take into account therapeutic recommendations, clinical research findings, and FDA-approved labeling.
Food and Drug Administration (FDA) Approved Products Labels
Professional Information regarding medications is provided on Food and Drug Administration product labels. Product monographs approved by the US Food and Drug Administration (FDA) and created by drug makers are presented in professional detail on Pillrecognizer.com. reformats these monographs in a manner similar to theirs, but the substance is identical to FDA-approved labeling.
National Library of Medicine
The fully referenced, peer-reviewed LactMed Database from the National Library of Medicine has a list of medications that nursing moms may come into contact with. The information includes drug levels in mothers and infants, potential effects on nursing and breastfed infants, and alternative medications to take into account.
Harvard Health Publications
Harvard Health Topics A to Z and the Harvard Health Decision Guides (which are used in our Symptom Checker) are published by Pillrecognizer.com. The Harvard Medical School at Harvard University’s publishing branch, Harvard Health Publications, uses the knowledge of its 9,000 faculty physicians to produce reliable and credible consumer health publications. Founded in 1782, the Harvard Medical School has 18 linked institutions and over 10,000 faculty members, including over 9,000 clinical physicians.
Medicine.com
New Drugs
News & Articles
This section offers a range of clinical and industry news stories targeted at health professionals regarding the development, efficacy, and safety of prescription and over-the-counter medications, as well as the most recent consumer health news. Medicines.com Healthday and our in-house editorial staff power Medical News. Since 1998, HealthDay has been an award-winning provider of health content and has developed into one of the top providers of news based on scientific evidence for health.
NOTE: Note that some of the news pieces in the news collection are syndicated, in contrast to other content on Pillrecognizer.com. Since Pillrecognizer.com hasn’t always peer evaluated these publications, we are unable to guarantee that they are accurate to the highest ethical standards. As needed, conduct additional research. It is imperative that you consult your physician.
Special Features
The Pillrecognizer.com database includes these additional interactive resources:
PILL RECOGNIZER:
Identification of Pills This function aids in the identification of unknown drugs. The FDA, National Library of Medicine, Cerner Multum, Micromedex, the manufacturer directly, and other sources offer the data and images for pill identification. Occasionally, this artwork is improved to make it easier to read.
Errors and Omissions :
Pillrecognizer.com understands that occasionally there may be inaccuracies or omissions in the drug information. Since our goal is to offer the most accurate and current drug information available online, we kindly request that users notify us right once of any inaccuracies in the content—including false or misleading statements—by getting in touch with us. Errors in the content of the site will be fixed within 48 hours. We’ve updated our Corrections & Addendums page with a list of the latest corrections.